PDF Cover

13c Urea Market

13c Urea Market

The market for 13c Urea was estimated at $231 million in 2024; it is anticipated to increase to $320 million by 2030, with projections indicating growth to around $420 million by 2035.

Report ID:DS1309071
Author:Vineet Pandey - Business Consultant
Published Date:November 2025
Datatree
Chemicals & Materials
Specialty Chemicals
13c Urea
Share
Report Summary
Table of Contents
Methodology
Market Data

Global 13c Urea Market Outlook

Revenue, 2024

$231M

Forecast, 2034

$397M

CAGR, 2024 - 2034

5.6%
The 13c Urea industry revenue is expected to be around $243.4 million in 2025 and expected to showcase growth with 5.6% CAGR between 2025 and 2034. The increasing popularity of 13C Urea highlights its growing importance in today's market scene. The continuous advancements in medicine play a role in driving this upward trend as 13C Urea is widely utilized for diagnostic purposes such as detecting Helicobacter pylori bacteria. Its continued significance stems from being non radioactive and non toxic making it a preferred option, for research and medical practices. Advancements in technology and the use of methods, with this substance are also helping expand its presence in the market.

13C Urea is an safe form of urea that is commonly used in the medical field due to its significance in conducting the Urea Breath Test (UBT). This test enables precise identification of stomach ulcers and various gastric issues triggered by H. pylori bacteria without being invasive in nature. The increasing occurrence of health problems along with the necessity, for prompt and trustworthy diagnostic procedures significantly fuels its popularity.

13c Urea market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034

Market Key Insights

  • The 13c Urea market is projected to grow from $230.5 million in 2024 to $397 million in 2034. This represents a CAGR of 5.6%, reflecting rising demand across Breath Tests for Helicobacter Pylori, Agricultural Usage and Pharmaceutical Research.

  • Cambridge Isotope Laboratories, RICHEN EUROPE, and Otsuka Pharmaceutical are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the 13c Urea market and are expected to observe the growth CAGR of 3.6% to 5.4% between 2024 and 2030.
  • Emerging markets including Brazil, Mexico and Vietnam are expected to observe highest growth with CAGR ranging between 6.4% to 7.7%.

  • Transition like Automation in Testing is expected to add $22.5 million to the 13c Urea market growth by 2030

  • The 13c Urea market is set to add $167 million between 2024 and 2034, with manufacturer targeting Research Activities & Pharmaceutical Manufacturing Application projected to gain a larger market share.
  • With

    increasing diagnosis of gastrointestinal disorders, and

    advancements in medical technology, 13c Urea market to expand 72% between 2024 and 2034.

13c urea market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the 13c Urea

Collaborations between companies and academic institutions can drive advancements in research and development efforts concerning urea products. We may see the emergence of diagnostic methods, through these partnerships that could ultimately boost the growth of the 13Carbon urea market.

Growth Opportunities in North America and Asia-Pacific

North America Outlook

In the North American region, the use of 13c Urea has greatly accelerated, primarily driven by its significant role in healthcare applications. The innovative technologies in medical diagnostics have boosted the demand for 13c Urea, owing to its non-radioactive nature and high accuracy in diagnosing gastrointestinal disorders. A diverse range of opportunities exists in this region for manufacturers, as U. S. leads the medical diagnostic technology advancements. The competition in this region remains high with leading global players adopting advanced production methodologies to enhance the production of 13C Urea for various therapeutic applications. The need to continuously innovate and develop high-quality 13c Urea constitutes a prime driver of the market and competition in the region.

Asia-Pacific Outlook

The Asia Pacific region is showing potential as a market for 13Carbon Urea due to rising investments in healthcare infrastructure in countries like China and India. The progress in breath tests for identifying Helicobacter pylori infection has broadened 13Carbon Ureas applications in this region. A heightened understanding of 13Carbon Ureas usefulness, in healthcare is opening doors for manufacturers to grab a portion of the market share. While the market is competitive overall the key factors that drive competition are the production strategies and the quality of 13C urea.

Market Dynamics and Supply Chain

01

Driver: Increasing Diagnosis of Gastrointestinal Disorders, and Integration of Precision Medicine

The significant increase in detecting digestive system issues like stomach ulcers has also created a thriving market for 13C Urea testing kits. The 13C Urea breath test has also become increasingly sought after for diagnosing Helicobacter pylori due, to a growing number of conditions worldwide.

The advancements in precision medicine have also opened up avenues for personalized treatment approaches and are also driving significant growth opportunities for 13C Urea as well. The strategic utilization of 13C Urea in tailored treatments is also particularly evident in its role in non invasive diagnostics and the monitoring of treatment effectiveness, in gastric illnesses—a key segment poised for market growth.


Advancements in technology have also played a crucial role in driving growth in the 13C Urea market by introducing non invasive diagnostic methods like 13C Urea breath tests, for detecting Helicobacter pylori infections accurately and safely without invasive procedures commonly seen before.

02

Restraint: Regulatory Compliance Hurdles

In the 13th century urea sector industry faces a hurdle in meeting strict regulatory standards. Businesses are required to follow guidelines and rules established by governmental and international bodies to guarantee the safety and effectiveness of their goods. The rigorous packaging regulations, environmental standards and product testing criteria increase production costs. Could lead to delays, in launching products into the market. This could potentially hinder market growth. Impact demand dynamics.

03

Opportunity: Untapped Potential in the Pharmaceutical Industry and Advancements in Medical Imaging

The increasing utilization of 13Carbon urea in the sector offers promising prospects for those involved in the industry as it finds considerable utility in medical diagnostics for identifying H. Pylori infection specifically. The integration of 13Carbon urea into diagnostic techniques could potentially result in higher financial gains, for the companies involved.


With ongoing progress in technology shaping the landscape of imaging practices today，the need for substances such as 13Carbon urea is rising due to their role, in producing detailed images of high quality. Through the exploration of imaging methods involving 13Carbon urea，there is a possibility of exploring market opportunities.

04

Challenge: High Pricing and Accessibility Concerns

One major challenge faced by the 13C Urea industry is its pricing that restricts access, for lower income and emerging markets despite its wide range of uses and applications.

Supply Chain Landscape

1
Raw Material Acquisition

Sigma Aldrich

Chemotech Ltd

2
Processing & Production

RICHEN EUROPE

Otsuka Pharmaceutical

3
Product Assembly

IsoLife

Medical Isotopes Inc

4
Distribution & Retail

Englewood Hospital

Rockwood Clinics

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of 13c Urea in Breath Tests for Helicobacter Pylori, Agricultural Usage & Pharmaceutical Research

Breath Tests for Helicobacter Pylori

in medical diagnostics is where 13C Urea finds its main application. Particularly in breath assessments meant for spotting the existence of Helicobacter pylori bacteria associated with stomach ulcers. The 13C tagged urea gets consumed along, with a meal; any Helicobacter pylori present breaks down the isotope. Releases it as carbon dioxide through exhalation. This process can be identified using either a mass spectrometer or an infrared spectrometer. Otsuka Pharmaceutical and DiagnOptics are players, in the field of diagnostics. They excel in breath tests that make use of the distinctive characteristics of 13C Urea.

Pharmaceutical Research

In research labs like those of Merck and Pfizer; 13C Urea finds an alternate use as a tracer, for studying metabolic processes in pharmacokinetics without causing harm to the subjects involved since the non radioactive isotope takes the place of regular urea in metabolic pathways for detailed analysis; this unique capability is valued for monitoring metabolic processes in real time during drug development and clinical trials.

Agricultural Usage

13 carbon urea is also utilized in the sector as a tracer isotope for studying nitrogen cycles – aiding in assessing how crops utilize nitrogen from fertilizers and the loss of nitrogen, from the soil.

Recent Developments

December 2024

PharmaTech has increased its production capabilities, for 13C urea to meet the rising demand.

November 2024

BioSolution Inc launched an upgraded iteration of 13C Urea tailored for the sector to strengthen its position, in the market further.

October 2024

Advanced MedTech introduced a line of diagnostic kits that make use of 13C Urea as part of their move, towards offering cutting edge healthcare solutions.

In the stage of affairs the popularity of 13C Urea has been steadily increasing due to the use of new methods and technologies. This upward pattern doesnt just show advancements in healthcare. Also highlights the growing need for non invasive diagnostic options, which are a key application, for 13C Urea.

Impact of Industry Transitions on the 13c Urea Market

As a core segment of the Specialty Chemicals industry, the 13c Urea market develops in line with broader industry shifts. Over recent years, transitions such as Automation in Testing and Research in Agriculture have redefined priorities across the Specialty Chemicals sector, influencing how the 13c Urea market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Automation in Testing

There has been a progress in the use of 13C urea in breath tests with the integration of automation technology being a key factor behind this advancement; leading to improved efficiency and accuracy while minimizing human mistakes. These enhancements have resulted in an increased need for 13C urea due to its nature and its essential role in these tests. The pharmaceutical and healthcare industries are experiencing a rise in demand, for diagnostic tools and patient care solutions as a result of this technological evolution.

This industry transition is expected to add $22.5 million in the industry revenue between 2024 and 2030.
02

Research in Agriculture

13C urea is increasingly playing a role in agricultural studies nowadays as it is utilized for assessing soil fertility levels and determining the nutrient requirements of crops and the effectiveness of fertilizers in farming practices with a sustainable approach in mind. For instance; the utilization of this isotope aids in measuring the decomposition of soil matter which is a crucial element in sustainable agricultural practices. Therefore; the growing trend towards farming methods has led to a notable rise in the demand, for 13C urea thereby impacting the agricultural industry significantly. The outcome is a market that holds promise for expansion, in both well established and up and coming economies.

Related Reports

Loading related reports...